Eberhard Wieland is Professor of Clinical Chemistry and Laboratory Medicine. He is Medical Director at the Synlab MVZ Medical Care Center in Leinfelden, Germany.
Dr. Wieland received his MD in Biochemistry from the Ruprecht-Karls-University, Heidelberg in 1982. He held a postdoctoral position at the Department of Endocrinology and Metabolism of the University of California, San Diego, USA between 1985 and 1987. From 1987 to 1993 he received his training in Clinical Chemistry and Laboratory Medicine at the Georg-August-University Goettingen, Germany. After a position as senior physician at the Department of Clinical Chemistry he became in 2003 Medical Director of the Central Institute for Clinical Chemistry and Laboratory Medicine, Klinikum Stuttgart, Germany.
Dr. Wieland is extraordinary professor at the Medical Faculty of the Eberhard-Karls-University in Tuebingen, Germany. He is Fellow (FEBLM/MB) and President of the UEMS European Board of Laboratory Medicine/Medical Biopathology as well as egistered European Specialist in Laboratory (EuSpLM).
Dr. Wieland has contributed over 100 articles to peer reviewed scientific journals and 16 book chapters on the topics TDM, atherosclerosis, oxidative stress, and biomarkers. He is editorial board member of Therapeutic Drug Monitoring (USA), Clinical Biochemistry (Canada), Clinical Laboratory (Germany), and Journal of Laboratory Medicine (Germany). He is chairman of the DAkkS (Deutsche Akkreditierungsstelle) working group on Good Laboratory Practice.
Prof. Dr. med. Eberhard Wieland, FEBLM/MB, EurSpLM
Synlab MVZ Medical Care Center Leinfelden, Germany